Literature DB >> 21490446

Clinical significance of the duplicated muscularis mucosae in Barrett esophagus-related superficial adenocarcinoma.

David K Kaneshiro1, Jane C Post, Lisa Rybicki, Thomas W Rice, John R Goldblum.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the relationship between the depth of invasion within the mucosal compartment, with particular attention to the duplicated muscularis mucosae, and survival after esophagectomy performed as treatment for Barrett esophagus-related superficial adenocarcinoma.
METHODS: A total of 185 patients with pT1 esophageal adenocarcinoma treated by esophagectomy without induction therapy were identified. Depth of invasion was subdivided into invasion into the lamina propria (LP), into the inner muscularis mucosae, between the inner and outer muscularis mucosae, and into the outer muscularis mucosae (OMM), with comparison with tumors invading the inner one third of the submucosa (SM-1). Patient and tumor characteristics were compared among the 5 groups using the χ test or the Kruskal-Wallis test. Survival was estimated using the Kaplan-Meier method and compared using the log-rank test. The prognostic effect of depth of invasion on survival was assessed with Cox proportional hazards analysis.
RESULTS: Depth of invasion was LP (n=68), inner muscularis mucosae (n=38), BMM (n=11), OMM (n=33), and SM-1 (n=35). There was no significant difference in sex or age among groups. One of 150 patients with intramucosal adenocarcinoma (0.7%; LP, pN2) and 3 of 35 patients with SM-1 (8.6%; all pN1) had nodal disease. There were no significant differences in survival among the groups.
CONCLUSIONS: Depth of invasion relative to the duplicated muscularis mucosae for tumors restricted to the mucosal compartment does not affect survival in Barrett esophagus-related superficial adenocarcinoma. Patients with SM-1 tumor had survival similar to those patients with tumor invasion into the OMM.

Entities:  

Mesh:

Year:  2011        PMID: 21490446     DOI: 10.1097/PAS.0b013e3182159c4b

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  6 in total

Review 1.  Two-year follow-up period showing the natural history of a superficial esophageal adenocarcinoma arising in a long segment of Barrett's esophagus.

Authors:  Junya Oguma; Soji Ozawa; Akihito Kazuno; Miho Nitta; Yamato Ninomiya; Sakura Tomita
Journal:  Clin J Gastroenterol       Date:  2016-09-02

Review 2.  The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review.

Authors:  Kerry B Dunbar; Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2012-06       Impact factor: 10.864

Review 3.  Pathological assessment of endoscopic resections of the gastrointestinal tract: a comprehensive clinicopathologic review.

Authors:  M Priyanthi Kumarasinghe; Michael J Bourke; Ian Brown; Peter V Draganov; Duncan McLeod; Catherine Streutker; Spiro Raftopoulos; Tetsuo Ushiku; Gregory Y Lauwers
Journal:  Mod Pathol       Date:  2020-01-06       Impact factor: 7.842

Review 4.  Treatment of dysplasia in barrett esophagus.

Authors:  Javier Aranda-Hernandez; Maria Cirocco; Norman Marcon
Journal:  Clin Endosc       Date:  2014-01-24

Review 5.  Histopathology in barrett esophagus and barrett esophagus-related dysplasia.

Authors:  Andrea Grin; Catherine J Streutker
Journal:  Clin Endosc       Date:  2014-01-24

6.  Tumor location is a risk factor for lymph node metastasis in superficial Barrett's adenocarcinoma.

Authors:  Masayoshi Yamada; Ichiro Oda; Hirohito Tanaka; Seiichiro Abe; Satoru Nonaka; Haruhisa Suzuki; Shigetaka Yoshinaga; Aya Kuchiba; Kazuo Koyanagi; Hiroyasu Igaki; Hirokazu Taniguchi; Shigeki Sekine; Yutaka Saito; Yuji Tachimori
Journal:  Endosc Int Open       Date:  2017-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.